Profusa, Inc. Files S-1 for Highly Dilutive Unit Offering Amidst Going Concern and Nasdaq Delisting Threats
PFSA is trading near its 52-week low of $2.65 (1.5% above the low) on light trading volume (0.3× avg).
Summary
Profusa, Inc. filed an S-1 registration statement for a best-efforts offering of up to 5.1 million Units (common stock and warrants), potentially raising $14.6 million, which represents over 400% immediate dilution and is critical for the company's continued operations and Nasdaq listing compliance.
Key Events · Financing and Capital Events · PFSA
-
Highly Dilutive Unit Offering
The company is offering up to 5,102,040 Units, each consisting of one share of common stock and two warrants, at an assumed price of $2.94 per Unit. This represents an immediate potential dilution of over 400% to existing shareholders, with total potential dilution exceeding 1600% if all warrants are exercised.
-
Critical Capital Raise
The offering aims to raise approximately $14.6 million, which is essential for working capital and repaying $2.3 million in high-interest convertible debt, as the company faces substantial doubt about its ability to continue as a going concern.
-
Nasdaq Delisting Pressure
This capital raise follows a 1-for-75 reverse stock split on February 9, 2026, implemented to address Nasdaq's minimum bid price requirement, with ongoing risks related to market value listing rules.
-
New Strategic Developments
The company disclosed a new exclusive license agreement with Mayo Clinic for oxygen measurement technology and the forgiveness of a $1.3 million Paycheck Protection Program (PPP) loan, both effective February 11, 2026.
Analysis · PFSA · Industrial Applications And Services
This S-1 filing reveals a critical juncture for Profusa, Inc., as it seeks substantial capital through a highly dilutive offering. The immediate potential dilution of over 400% from the Units alone, and over 1600% if all warrants are exercised, signals severe financial distress. The $14.6 million expected proceeds are vital for the company, which explicitly states "substantial doubt about our ability to continue as a going concern" and is actively battling Nasdaq delisting threats, having recently completed a 1-for-75 reverse stock split. While the new Mayo Clinic license and the $1.3 million PPP loan forgiveness offer some positive operational and financial relief, the company's decision to invest $2.0 million in Bitcoin and its intention for it to become a "substantial majority of our assets" introduces a highly speculative and volatile element to its balance sheet, further increasing investor risk. The offering, priced at the recent market level, is a necessary but costly measure to secure short-term survival and address immediate financial and regulatory challenges.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PFSA was trading at $2.69 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $2.65 to $975.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.